Michael R. Schrimpf

1.3k total citations
22 papers, 968 citations indexed

About

Michael R. Schrimpf is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, Michael R. Schrimpf has authored 22 papers receiving a total of 968 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 8 papers in Organic Chemistry and 6 papers in Pharmacology. Recurrent topics in Michael R. Schrimpf's work include Nicotinic Acetylcholine Receptors Study (12 papers), Receptor Mechanisms and Signaling (8 papers) and Cholinesterase and Neurodegenerative Diseases (6 papers). Michael R. Schrimpf is often cited by papers focused on Nicotinic Acetylcholine Receptors Study (12 papers), Receptor Mechanisms and Signaling (8 papers) and Cholinesterase and Neurodegenerative Diseases (6 papers). Michael R. Schrimpf collaborates with scholars based in United States, United Kingdom and Denmark. Michael R. Schrimpf's co-authors include Edwin Vedējs, Stephen C. Fields, Shu-Chen Lin, William H. Bunnelle, Michael J. Dart, Douglas R. Powell, David J. Anderson, Shawn R. Hitchcock, Ryuji Hayashi and Michael D. Meyer and has published in prestigious journals such as Journal of the American Chemical Society, Chemical Communications and Journal of Medicinal Chemistry.

In The Last Decade

Michael R. Schrimpf

22 papers receiving 942 citations

Peers

Michael R. Schrimpf
Francesca Bartoccini Italy
Ippolito Antonini Italy
Dieter Muri Switzerland
Denis E. Ryono United States
Norihiro Ikemoto United States
Robert E. Zelle United States
John Hynes United States
Christopher A. Teleha United States
Paul A. Stupple United Kingdom
Yong‐Jin Wu United States
Francesca Bartoccini Italy
Michael R. Schrimpf
Citations per year, relative to Michael R. Schrimpf Michael R. Schrimpf (= 1×) peers Francesca Bartoccini

Countries citing papers authored by Michael R. Schrimpf

Since Specialization
Citations

This map shows the geographic impact of Michael R. Schrimpf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael R. Schrimpf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael R. Schrimpf more than expected).

Fields of papers citing papers by Michael R. Schrimpf

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael R. Schrimpf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael R. Schrimpf. The network helps show where Michael R. Schrimpf may publish in the future.

Co-authorship network of co-authors of Michael R. Schrimpf

This figure shows the co-authorship network connecting the top 25 collaborators of Michael R. Schrimpf. A scholar is included among the top collaborators of Michael R. Schrimpf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael R. Schrimpf. Michael R. Schrimpf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kovar, Peter, Paul L. Richardson, Alla Korepanova, et al.. (2024). Development of a sensitive high-throughput enzymatic assay capable of measuring sub-nanomolar inhibitors of SARS-CoV2 Mpro. SLAS DISCOVERY. 29(6). 100179–100179. 1 indexed citations
2.
3.
Horti, Andrew G., Hayden T. Ravert, Gao Y, et al.. (2013). Synthesis and evaluation of new radioligands [11C]A-833834 and [11C]A-752274 for positron-emission tomography of α7-nicotinic acetylcholine receptors. Nuclear Medicine and Biology. 40(3). 395–402. 17 indexed citations
4.
Beebe, Xenia, Clinton M. Yeung, Shashank Shekhar, et al.. (2013). Synthesis and SAR of 4-aminocyclopentapyrrolidines as orally active N-type calcium channel inhibitors for inflammatory and neuropathic pain. Bioorganic & Medicinal Chemistry Letters. 23(17). 4857–4861. 7 indexed citations
5.
6.
Swensen, Andrew M., Wende Niforatos, Timothy A. Vortherms, et al.. (2012). An Automated Electrophysiological Assay for Differentiating Ca V 2.2 Inhibitors Based on State Dependence and Kinetics. Assay and Drug Development Technologies. 10(6). 542–550. 4 indexed citations
7.
Schrimpf, Michael R., Clark A. Briggs, David J. Anderson, et al.. (2012). SAR of α7 nicotinic receptor agonists derived from tilorone: Exploration of a novel nicotinic pharmacophore. Bioorganic & Medicinal Chemistry Letters. 22(4). 1633–1638. 26 indexed citations
8.
Li, Tao, William H. Bunnelle, Keith B. Ryther, et al.. (2010). Syntheses and structure–activity relationship (SAR) studies of 2,5-diazabicyclo[2.2.1]heptanes as novel α7 neuronal nicotinic receptor (NNR) ligands. Bioorganic & Medicinal Chemistry Letters. 20(12). 3636–3639. 10 indexed citations
9.
Anderson, David J., et al.. (2009). Preparation and characterization of N-(3-pyridinyl) spirocyclic diamines as ligands for nicotinic acetylcholine receptors. Bioorganic & Medicinal Chemistry Letters. 19(6). 1682–1685. 27 indexed citations
10.
Mortell, Kathleen H., Michael R. Schrimpf, William H. Bunnelle, et al.. (2009). Structure–activity relationships of N-substituted ligands for the α7 nicotinic acetylcholine receptor. Bioorganic & Medicinal Chemistry Letters. 20(1). 104–107. 4 indexed citations
11.
Briggs, Clark A., Michael R. Schrimpf, David J. Anderson, et al.. (2007). α7 nicotinic acetylcholine receptor agonist properties of tilorone and related tricyclic analogues. British Journal of Pharmacology. 153(5). 1054–1061. 26 indexed citations
12.
Ji, Jianguo, Michael R. Schrimpf, William H. Bunnelle, et al.. (2007). Synthesis and Structure−Activity Relationship Studies of 3,6-Diazabicyclo[3.2.0]heptanes as Novel α4β2 Nicotinic Acetylcholine Receptor Selective Agonists. Journal of Medicinal Chemistry. 50(22). 5493–5508. 40 indexed citations
13.
Bunnelle, William H., Jerome F. Daanen, Keith B. Ryther, et al.. (2007). Structure−Activity Studies and Analgesic Efficacy ofN-(3-Pyridinyl)-Bridged Bicyclic Diamines, Exceptionally Potent Agonists at Nicotinic Acetylcholine Receptors. Journal of Medicinal Chemistry. 50(15). 3627–3644. 44 indexed citations
14.
Ji, Jianguo, William H. Bunnelle, Tao Li, et al.. (2005). Discovery of fused azetidines as novel selective α4β2 neuronal nicotinic receptor (NNR) agonists. Pure and Applied Chemistry. 77(12). 2041–2045. 9 indexed citations
15.
Bunnelle, William H., Michael J. Dart, & Michael R. Schrimpf. (2004). Design of Ligands for the Nicotinic Acetylcholine Receptors:The Quest for Selectivity. Current Topics in Medicinal Chemistry. 4(3). 299–334. 69 indexed citations
16.
Dart, Michael J., James T. Wasicak, Keith B. Ryther, et al.. (2000). Structural aspects of high affinity ligands for the α4β2 neuronal nicotinic receptor. Pharmaceutica Acta Helvetiae. 74(2-3). 115–123. 29 indexed citations
17.
Vedējs, Edwin, Stephen C. Fields, Ryuji Hayashi, et al.. (1999). Asymmetric Memory at Labile, Stereogenic Boron:  Enolate Alkylation of Oxazaborolidinones. Journal of the American Chemical Society. 121(11). 2460–2470. 102 indexed citations
18.
Vedējs, Edwin, et al.. (1996). Generation of reactive borenium ions in the 2,3-benzazaborolidine series. Chemical Communications. 2721–2721. 22 indexed citations
19.
Vedējs, Edwin, Stephen C. Fields, Sheng‐Jia Lin, & Michael R. Schrimpf. (1995). Asymmetric Transformation in Boron Ate Complexes of Amino Acids. The Journal of Organic Chemistry. 60(10). 3028–3034. 43 indexed citations
20.
Vedējs, Edwin, Stephen C. Fields, & Michael R. Schrimpf. (1993). Asymmetric transformation in synthesis: chiral amino acid enolate equivalents. Journal of the American Chemical Society. 115(24). 11612–11613. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Francesca Bartoccini Breakdown of academic impact, for papers by Ippolito Antonini Breakdown of academic impact, for papers by Dieter Muri Breakdown of academic impact, for papers by Denis E. Ryono Breakdown of academic impact, for papers by Norihiro Ikemoto Breakdown of academic impact, for papers by Robert E. Zelle Breakdown of academic impact, for papers by John Hynes Breakdown of academic impact, for papers by Christopher A. Teleha Breakdown of academic impact, for papers by Paul A. Stupple Breakdown of academic impact, for papers by Yong‐Jin Wu
Rankless by CCL
2026